-
Transparency Tested: Conflict of Interest in EU HTA
Sep 9, 2025, 16:22 PM -
Perspectives on Progress: A Qualitative Study of HIV Prevention Efforts in the Czech Republic
Sep 9, 2025, 16:22 PM -
What Generalized Cost-Effectiveness Analysis (GCEA) Reveals About the Applicability of Foreign Reference Pricing in Medicare Price Negotiation in the US
Sep 9, 2025, 16:22 PM -
Therapeutic Potential of Bispecific Antibodies in Adenocarcinoma: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Public Health and Economic Effects of Various RSV Vaccination Strategies With RSVpreF Among Adults in France
Sep 9, 2025, 16:22 PM -
Evaluating Clinical Similarity: A Systematic Review of Methods Used Within National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) When Relying on Statistically Nonsignificant Differences From Indirect Treatment...
Sep 9, 2025, 16:22 PM -
Utility of Minimum Dataset for Generation of Real-World Data in a Context With Evidence Gaps: The Left Ventricular Assist Devices as Destination Therapy
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pharmacogenetic Testing to Guide Treatment for Children With Asthma
Sep 9, 2025, 16:22 PM -
Content Validation of a Modified PozQoL for Assessing HIV Therapies
Sep 9, 2025, 16:22 PM -
Incentivizing Access to New Drugs in Psychiatry: Exploration of a Subscription Payment Approach to Overcome Barriers to European Launch
Sep 9, 2025, 16:22 PM -
The Costs of Loneliness-Related Health Consequences in Finland
Sep 9, 2025, 16:22 PM -
CAR-T Therapy in Asia-Pacific: Is It Reimbursed in Your Country?
Sep 9, 2025, 16:22 PM -
Barriers and Policy Solutions in Off-Patent Drug Repurposing: A Full-Life-Cycle Perspective
Sep 9, 2025, 16:22 PM -
Economic Impact of Emicizumab vs. On-Demand Therapy With Bypassing Agents in Patients With Hemophilia A With Inhibitors in Mexico
Sep 9, 2025, 16:22 PM -
Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Atopic Dermatitis in Poland in Comparison With Efficacy Reported in Clinical Trials
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of an AI-Based Smartphone App for the Early Detection of Skin Cancer: A Decision Tree Analysis
Sep 9, 2025, 16:22 PM -
Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset
Sep 9, 2025, 16:22 PM -
Financial Impact of EU MDR Compliance: A Cost-Mapping Assessment for Manufacturers
Sep 9, 2025, 16:22 PM
